ALFA Finder| Revenue growth | 33.2% YoY Consolidated growth. |
|---|---|
| Margins | Consolidated EBITDA margins stable at 19.9% vs 19.6% YoY. |
| Demand visibility | Strong; patient volumes and surgical activity increasing. |
| Management confidence | High; expanding regional presence beyond Dhanbad. |
Growth
Revenue up 33.2%, EBITDA up 35.3%, and PAT up 36.7% YoY on a consolidated basis.
Outlook
Focusing on migrating to the Main Board, expanding referral networks, and enhancing specialized cancer care infrastructure.
Risks
Surgical Oncology revenue declined 53% due to lower complex surgery volumes and case realizations.
Last quarter's promises, checked
Delivered
- Guided FY27 Revenue ₹260 Cr → Current Q1 ₹47.5 Cr (= BEAT)
- Guided EBITDA Margin 23-25% → Q1 19.9% (= PARTIAL)
- Guided Main Board Migration after July → Initiated process (= BEAT)
Partly delivered
- Guided Bed Capacity 500+ by 2028 → Added 50 beds in Ranguni (= PARTIAL)
Missed
- Guided Bone Marrow Facility live FY26 → Still pending approval (= MISS)
- Guided Cancer Unit occupancy growth → Surgical Oncology revenue fell 53% (= MISS)
Investor Presentation filed with BSE, BSE: 543943. Summary written with AI assistance from the document.
Asarfi Hospital Ltd: key numbers
- Share price
- ₹183.00
- Market cap
- ₹360.1 Cr
- Revenue (annual)
- ₹173.5 Cr
- Net profit (annual)
- ₹16.66 Cr
- P/E (TTM)
- 21.6×Sector 35.3×
- Promoter holding
- 61.18%+0.01% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Asarfi Hospital Ltd
All →Asarfi Hospital Other Announcement
Asarfi Hospital Limited filed its half-yearly shareholding pattern under Regulation 31(1)(b) for the period ended 30 September 2026. The filing shows promoter and public holdings, with no transaction or corporate event.
Asarfi Hospital Other Announcement
Asarfi Hospital Ltd has filed its shareholding pattern for the quarter ended September 30, 2026. This disclosure outlines the current distribution of equity shares.
Asarfi Hospital Credit Rating
Asarfi Hospital Ltd announced that CRISIL Ratings upgraded its bank facilities credit rating. The total rated bank facilities are now ₹60 Crore, enhanced from ₹46.5 Crore.
- Value
- ₹60.00 Cr
Asarfi Hospital Annual General Meeting
Asarfi Hospital Ltd's 21st Annual General Meeting held on September 18, 2026, saw shareholder approval for financial statements, director reappointment, and migration to the BSE Main Board.
Asarfi Hospital Annual Report
Asarfi Hospital Limited has submitted its Annual Report for the Financial Year 2025-26 in compliance with SEBI Listing Regulations.
Asarfi Hospital Other Announcement
Asarfi Hospital Limited has appointed M/s Ashutosh Kumar Sinha & Co as the Cost Auditor for the financial year 2026-27, as approved by the Board.